VDR and myeloid sarcoma: Recently, Jin et al. determined that VDR polymorphisms, including ApaI, BsmI, FokI, and TaqI, were not associated with the risk of MS; however, the ApaI variant was associated with hypertriglyceridemia, and the BsmI and TaqI variants were associated with high-density lipoprotein cholesterol (HDL-c) in adults [23].